JASN Podcast cover art

All Episodes

JASN Podcast — 87 episodes

#
Title
1

A Target Trial Emulation of GLP1RA, SGLT2i or DPP4i as Add on Treatment in CKD

2

Temporal, Cell-Specific Angiopoietin-2 in CKD

3

Cardiovascular Effects of GLP-1 RA in Kidney Failure

4

ASN Kidney Translation Series: Artificial Intelligence in Nephrology

5

Subclinical Primary Aldosteronism and eGFR Decline

6

ASN Kidney Translation Series: Peritoneal Dialysis

7

PD Use in Health Service Areas, 2009–2020

8

ASN Kidney Translation Series: ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure

9

LCN2-Induced CLUH Inhibition Disrupts Mitochondria in Kidney

10

ASN Kidney Translation Series: Kidney Transplant Advances

11

Automatic Organ and Cyst Volumes in ADPKD

12

Coronary Disease Screening Prior to Kidney Transplant

13

ASN Kidney Translation Series: Advances in Glomerular Filtration Rate

14

Bone Marrow Inflammation Drives Glomerular Damage

15

ICD Code Accuracy for CVD in CKD

16

Dapagliflozin and HRQoL in Patients with CKD

17

ASN Kidney Translation Series: Glomerulonephritis

18

RNA Sequencing of IgA Nephropathy Kidneys

19

Alternative Splicing and Polyadenylation in Glomerular Disease

20

The PEER-HD Randomized Controlled Trial

21

SGLT2 Inhibitors and Risk of Urinary Tract Infections with Abnormal Genitourinary Pathology

22

Disaster Management in Kidney Care

23

Regulation of Renal Glucose Handling by mTORC2

24

Drug Screening in Drosophila Nephrocytes

25

ASN Kidney Translation Series: ADPKD Advances

26

Anticoagulation in Dialysis Recipients with Atrial Fibrillation

27

CASR Determines Renal Response to Hypercalcemia

28

ASN Kidney Translation Series: ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury

29

ASN Kidney Translation Series: Kidney Stones

30

Molecular Signature of NPCs in the Catshark

31

Acetazolamide and the Kidney in T1D

32

Kidney Protection by Acetylcholine

33

ASN Kidney Translation Series: Genetic Testing in Nephrology

34

ASN Kidney Translation Series: Novel Therapies for IgA Nephropathy

35

Polycystin-2 Regulates Natriuretic Peptide Production

36

ASN Kidney Translation Series: ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases

37

KLF15 Agonist in Kidney Disease

38

Stem Cells in Renovascular Disease

39

ASN Kidney Translation Series: Gender Equity in Nephrology

40

Tubular Effect of Proteinuria

41

sGC Activator Avenciguat for CKD

42

Absolute CKD Progression Risk

43

Set7 Regulates Glomerular Injury

44

ASN Kidney Translation Series: PPI, Antivirals, and Cough Syrups: Nephrotoxins and Kidney Injury

45

Daprodustat and Heart Failure in CKD

46

Changes in ESKD Incidence

47

The Final JASN Podcast

48

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

49

Kidney Transplant Registry Data: Advice for Users

50

Historical Redlining and the Incidence of Kidney Failure in US Cities

51

Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease

52

Antibiotic Use & Kidney Stones and Sodium Bicarbonate & the Vascular Dysfunction of CKD

53

How Many Nephrons in a Human Kidney? A New Number and a Discussion of Why it Matters

54

The Angiopoietin-Tie 2 Pathway is Ischemic Kidney Injury

55

Urea and Uremia

56

Use of Kidney Organoids to Study Steroid-Resistant Nephrotic Syndrome

57

A Conversation with Deidre Crews and Tanjala Purnell about COVID-19, Structural Racism and Kidney Disease

58

A Discussion with Andrew Malone and Madhav Menon: RNAseq and the Transplant Biopsy, What is New?

59

A Dialogue with Mahboob Rahman and Erin Barreto About Ambulatory Blood Pressure Monitoring in Patients with Chronic Kidney Disease

60

A Conversation with Mark Knepper and Josie Briggs: Does SARS-CoV2 Infect the Kidney?

61

JASN January 2021 Issue Highlights

62

JASN February 2021 Issue Highlights

63

JASN March 2021 Issue Highlights

64

JASN April 2021 Issue Highlights

65

JASN May 2022 Issue Highlights

66

New Insights into the Mechanisms of Kidney Disease: Understanding Hypercholesterolemia in CKD; ADAM10 and Immune Injury to the Podocyte Slit Diaphragm

67

COVID-19 Mortality and the Tough Discussions about Advance Care Planning

68

Vaccine Acceptability and Hemodialysis Patients

69

The Extracellular Matrix in Development, Aging, and Disease

70

Lost Opportunities for Kidney Transplant

71

JASN August 2021 Issue Highlights

72

New Directions for Clinical Trials in Kidney Disease

73

JASN October 2021 Issue Highlights

74

JASN November 2021 Issue Highlights

75

The Immune Responses to COVID-19 in Transplant Patients

76

Insights into Collapsing Glomerulopathy

77

Lowering GFR to Protect GFR!

78

The Renal Framingham - CVD Prediction

79

Roxadustat and the Interpretation of Non-Inferiority

80

JASN May 2022 Highlights: Inflammation as a Driver of CKD Progression

81

A New Approach to Advance Care Planning for Dialysis Decisions: Deciding not to Decide

82

Discontinuing Immunosuppressant Use after Allograft Failure: Do We Have the Answers?

83

Addressing Racial and Ethnic Disparities in Kidney Disease

84

August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension

85

Climate Change: Implications for Nephrology

86

Gender Differences in Care of CKD Patients

87

Comparing Costs of Hemodialysis and Peritoneal Dialysis